Showing 1 - 11 results of 11 for search 'Croce D', query time: 0.11s Refine Results
  1. 1
    Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives

    Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives by Croce D, Bonfanti M, Restelli U

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review

    Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review by Silvola S, Restelli U, Bonfanti M, Croce D

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Change and Innovation in Healthcare: Findings from Literature

    Change and Innovation in Healthcare: Findings from Literature by Milella F, Minelli EA, Strozzi F, Croce D

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

    Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... by Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

    Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... by Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

    Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies... by Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications

    Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications by Foglia E, Ferrario L, Garagiola E, Signoriello G, Pellino G, Croce D, Canonico S

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients

    Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatm... by Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?

    Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile? by Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

    Published 2012
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service

    Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service by Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

    Published 2014
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?

    A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation? by Galli T, Mirata P, Foglia E, Croce D, Porazzi E, Ferrario L, Ricci E, Garagiola E, Pagani R, Banfi G

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: